Growing cancer incidence and mortality worldwide demands development of accurate
biomarkers to perfect detection, diagnosis, prognostication and monitoring. Urologic …

Solid cancers are one of the leading causes of cancer related deaths, characterized by rapid
growth of tumour, and local and distant metastases. Current advances on multimodality care …

Exosomes, cell-derived vesicles of endosomal origin, are continuously released in the
extracellular environment and play a key role in intercellular crosstalk. In this study, we have …

Serum biomarkers are molecules produced by normal and abnormal cells. Prostate specific
antigen (PSA) is an example of a serum biomarker used widely in the diagnosis and …

Rapid on-site electrochemical screening for prostate cancer (PCa) in the clinic holds the
potential for early diagnosis of PCa patients. Currently, the accuracy of commonly used …

Following the introduction of routine Prostate Specific Antigen (PSA) screening in the early
1990′ s, Prostate Cancer (PCa) is often detected at an early stage. There are also a …

Background: Clinically, it is still challenging to differentiate aggressive from non-aggressive
prostate cancers (Pca) by non-invasive approaches. Our recent studies showed that …

The nine FDA-approved protein biomarkers for the diagnosis and management of cancer
are approaching maturity, but their different glycosylation compositions relevant to early …

Prostate cancer (PCa) remains one of the most prominent forms of cancer for men. Since the
early 1990s, Prostate-Specific Antigen (PSA) has been a commonly recognized PCa …

Berberine is a well‑known component of the Chinese herbal medicine Huanglian (Coptis
chinensis), and is capable of inhibiting the proliferation of multiple cancer cell lines …